tiprankstipranks
Nippon Shokubai Co., Ltd. (JP:4114)
:4114
Japanese Market
Want to see JP:4114 full AI Analyst Report?

Nippon Shokubai Co., Ltd. (4114) AI Stock Analysis

1 Followers

Top Page

JP:4114

Nippon Shokubai Co., Ltd.

(4114)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 5.2)
Rating:69Neutral
Price Target:
¥2,319.00
▲(21.99% Upside)
Action:DowngradedDate:02/07/26
The score is primarily supported by a conservative balance sheet and improving profitability versus 2024, but constrained by the sharp reported revenue decline and weak free cash flow conversion. Technicals are strong (price above major moving averages), though overbought signals add near-term risk, while valuation is helped by a high dividend yield but tempered by a mid-range P/E.
Positive Factors
Conservative balance sheet
Low leverage and a large equity base provide durable financial resilience across cycles. This supports funding for maintenance capex, selective investments, dividend stability and stronger creditor standing, reducing refinancing and distress risk over the next several months to years.
Negative Factors
Sharp revenue decline
A dramatic top-line drop materially reduces scale economics and undermines forecasting reliability. Lower volumes and revenues tighten fixed-cost absorption in continuous chemical plants, pressuring margins and capital returns until volumes or pricing recover sustainably.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Low leverage and a large equity base provide durable financial resilience across cycles. This supports funding for maintenance capex, selective investments, dividend stability and stronger creditor standing, reducing refinancing and distress risk over the next several months to years.
Read all positive factors

Nippon Shokubai Co., Ltd. (4114) vs. iShares MSCI Japan ETF (EWJ)

Nippon Shokubai Co., Ltd. Business Overview & Revenue Model

Company Description
Nippon Shokubai Co., Ltd. is a leading chemical manufacturer based in Japan, specializing in the production of a wide range of chemical products including superabsorbent polymers, catalysts, and specialty chemicals. The company operates primarily ...
How the Company Makes Money
Nippon Shokubai primarily makes money by manufacturing chemical products and selling them to industrial and consumer-product supply chains under business-to-business contracts. Its key revenue streams are (1) superabsorbent polymers (SAP), where e...

Nippon Shokubai Co., Ltd. Financial Statement Overview

Summary
Balance sheet strength and low leverage (TTM debt-to-equity ~0.14) support stability, and profitability has improved versus 2024 (TTM net income ¥17.7B vs ¥11.0B). Offsetting this, the latest period shows a sharp TTM revenue decline (reported growth -64.8%) and weaker cash-flow quality with low free cash flow conversion (TTM FCF ¥7.7B vs operating cash flow ¥47.9B).
Income Statement
66
Positive
Balance Sheet
78
Positive
Cash Flow
58
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue400.06B409.35B392.01B419.57B369.29B273.16B
Gross Profit73.80B71.82B69.42B81.78B79.11B49.28B
EBITDA49.39B48.47B47.98B52.86B57.59B35.60B
Net Income17.74B17.39B11.01B19.39B23.72B-10.90B
Balance Sheet
Total Assets564.71B543.66B544.06B523.32B518.15B471.62B
Cash, Cash Equivalents and Short-Term Investments50.71B54.56B55.13B39.03B39.36B36.34B
Total Debt52.97B46.57B45.61B57.61B59.68B61.57B
Total Liabilities167.50B151.13B151.50B153.32B167.03B147.89B
Stockholders Equity387.73B383.03B383.45B362.23B343.88B317.37B
Cash Flow
Free Cash Flow7.75B13.05B38.73B19.80B14.87B5.62B
Operating Cash Flow47.86B46.97B57.88B41.45B35.06B35.28B
Investing Cash Flow-38.51B-30.51B-15.68B-25.98B-23.16B-30.62B
Financing Cash Flow-20.14B-16.78B-28.36B-17.32B-10.75B-12.75B

Nippon Shokubai Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1901.00
Price Trends
50DMA
2328.15
Negative
100DMA
2149.07
Positive
200DMA
1930.24
Positive
Market Momentum
MACD
-24.65
Positive
RSI
38.84
Neutral
STOCH
2.15
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4114, the sentiment is Neutral. The current price of 1901 is below the 20-day moving average (MA) of 2263.20, below the 50-day MA of 2328.15, and below the 200-day MA of 1930.24, indicating a neutral trend. The MACD of -24.65 indicates Positive momentum. The RSI at 38.84 is Neutral, neither overbought nor oversold. The STOCH value of 2.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4114.

Nippon Shokubai Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
84
Outperform
¥13.71T18.0411.19%2.17%1.76%-6.83%
69
Neutral
¥316.04B10.965.28%-2.01%19.12%
66
Neutral
¥760.52B10.744.79%4.21%-2.82%-46.83%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
¥825.60B3.838.79%2.68%-5.39%
60
Neutral
¥494.37B-8.311.02%3.37%-2.23%-77.42%
55
Neutral
¥1.20T-66.091.09%3.50%-14.76%25.27%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4114
Nippon Shokubai Co., Ltd.
2,153.00
556.87
34.89%
JP:3405
Kuraray Co
1,659.00
47.46
2.94%
JP:4188
Mitsubishi Chemical Holdings
918.30
251.37
37.69%
JP:4063
Shin-Etsu Chemical Co
7,081.00
2,835.76
66.80%
JP:4005
Sumitomo Chemical Co
508.60
174.17
52.08%
JP:4042
Tosoh
2,415.00
490.70
25.50%

Nippon Shokubai Co., Ltd. Corporate Events

Nippon Shokubai Holds Profit Amid Lower Sales, Keeps FY2025 Outlook Unchanged
Feb 5, 2026
For the nine months ended December 31, 2025, Nippon Shokubai reported revenue of ¥299.3 billion, down 3.0% year on year, while operating profit was essentially flat at ¥15.2 billion and profit attributable to owners of the parent rose 2....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026